177 related articles for article (PubMed ID: 31794591)
1. A siRNA mediated hepatic dpp4 knockdown affects lipid, but not glucose metabolism in diabetic mice.
Görgens SW; Jahn-Hofmann K; Bangari D; Cummings S; Metz-Weidmann C; Schwahn U; Wohlfart P; Schäfer M; Bielohuby M
PLoS One; 2019; 14(12):e0225835. PubMed ID: 31794591
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide.
Long Z; Cao M; Su S; Wu G; Meng F; Wu H; Liu J; Yu W; Atabai K; Wang X
Free Radic Biol Med; 2017 Dec; 113():71-83. PubMed ID: 28942246
[TBL] [Abstract][Full Text] [Related]
3. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
[TBL] [Abstract][Full Text] [Related]
4. Citrus unshiu peel extract ameliorates hyperglycemia and hepatic steatosis by altering inflammation and hepatic glucose- and lipid-regulating enzymes in db/db mice.
Park HJ; Jung UJ; Cho SJ; Jung HK; Shim S; Choi MS
J Nutr Biochem; 2013 Feb; 24(2):419-27. PubMed ID: 22694954
[TBL] [Abstract][Full Text] [Related]
5. Adipose-derived stromal cells reverse insulin resistance through inhibition of M1 expression in a type 2 diabetes mellitus mouse model.
Chen LW; Chen PH; Tang CH; Yen JH
Stem Cell Res Ther; 2022 Jul; 13(1):357. PubMed ID: 35883204
[TBL] [Abstract][Full Text] [Related]
6. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes.
Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH
Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting adipose tissue M1 cytokine expression decreases DPP4 activity and insulin resistance in a type 2 diabetes mellitus mouse model.
Chen LW; Chen PH; Yen JH
PLoS One; 2021; 16(5):e0252153. PubMed ID: 34043673
[TBL] [Abstract][Full Text] [Related]
8. DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes.
Kim MK; Chae YN; Kim HD; Yang EK; Cho EJ; Choi SH; Cheong YH; Kim HS; Kim HJ; Jo YW; Son MH; Kim SH; Shin CY
Life Sci; 2012 Jan; 90(1-2):21-9. PubMed ID: 22056373
[TBL] [Abstract][Full Text] [Related]
9. Biological function of dipeptidyl peptidase-4 on type 2 diabetes patients and diabetic mice.
Qiao J; Li L; Ma Y; Shi R; Teng M
Curr Res Transl Med; 2019 Aug; 67(3):89-92. PubMed ID: 30591375
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic vaccine against DPP4 improves glucose metabolism in mice.
Pang Z; Nakagami H; Osako MK; Koriyama H; Nakagami F; Tomioka H; Shimamura M; Kurinami H; Takami Y; Morishita R; Rakugi H
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1256-63. PubMed ID: 24639549
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.
Mulvihill EE
Peptides; 2018 Feb; 100():158-164. PubMed ID: 29412815
[TBL] [Abstract][Full Text] [Related]
12. Hepatic DPP4 DNA Methylation Associates With Fatty Liver.
Baumeier C; Saussenthaler S; Kammel A; Jähnert M; Schlüter L; Hesse D; Canouil M; Lobbens S; Caiazzo R; Raverdy V; Pattou F; Nilsson E; Pihlajamäki J; Ling C; Froguel P; Schürmann A; Schwenk RW
Diabetes; 2017 Jan; 66(1):25-35. PubMed ID: 27999105
[TBL] [Abstract][Full Text] [Related]
13. Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition.
Varin EM; Mulvihill EE; Beaudry JL; Pujadas G; Fuchs S; Tanti JF; Fazio S; Kaur K; Cao X; Baggio LL; Matthews D; Campbell JE; Drucker DJ
Cell Metab; 2019 Feb; 29(2):320-334.e5. PubMed ID: 30393019
[TBL] [Abstract][Full Text] [Related]
14. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
[TBL] [Abstract][Full Text] [Related]
15. Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice.
Ziegler N; Raichur S; Brunner B; Hemmann U; Stolte M; Schwahn U; Prochnow HP; Metz-Weidmann C; Tennagels N; Margerie D; Wohlfart P; Bielohuby M
Front Endocrinol (Lausanne); 2020; 11():598. PubMed ID: 32982982
[TBL] [Abstract][Full Text] [Related]
16. Separate influences of insulin and hyperglycemia on hepatic drug metabolism in mice with genetic and chemically induced diabetes mellitus.
Knodell RG; Handwerger BS; Morley JE; Levine AS; Brown DM
J Pharmacol Exp Ther; 1984 Jul; 230(1):256-62. PubMed ID: 6379147
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat-Fed Diabetic Mice.
Mulvihill EE; Varin EM; Ussher JR; Campbell JE; Bang KW; Abdullah T; Baggio LL; Drucker DJ
Diabetes; 2016 Mar; 65(3):742-54. PubMed ID: 26672095
[TBL] [Abstract][Full Text] [Related]
18. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
[TBL] [Abstract][Full Text] [Related]
19. Mouse KLF11 regulates hepatic lipid metabolism.
Zhang H; Chen Q; Yang M; Zhu B; Cui Y; Xue Y; Gong N; Cui A; Wang M; Shen L; Zhang S; Fang F; Chang Y
J Hepatol; 2013 Apr; 58(4):763-70. PubMed ID: 23183531
[TBL] [Abstract][Full Text] [Related]
20. Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice.
Nam DH; Lee MH; Kim JE; Song HK; Kang YS; Lee JE; Kim HW; Cha JJ; Hyun YY; Kim SH; Han SY; Han KH; Han JY; Cha DR
Endocrinology; 2012 Mar; 153(3):1387-96. PubMed ID: 22234468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
